Prospective Use of Philips iSuite for Interventional Procedures
1 other identifier
interventional
12
1 country
1
Brief Summary
This research study is being done to look at new MRI imaging guidance software, Philips Interventional iSuite software, to see if using will improve the physician's ability to quickly place and guide needle tip position for biopsies and ablations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Jun 2021
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2018
CompletedFirst Posted
Study publicly available on registry
February 14, 2018
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 1, 2026
March 1, 2026
5.6 years
January 2, 2018
March 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Needle placement efficiency into target lesion
Needle placement efficiency record time to final needle position, and compare overall similarity of use with current CT guided intervention during the interventional procedure in order to determine how the iSuite may facilitate intervention with the MRI environment. Each operator will fill out a short questionnaire after each intervention.
Baseline (completion of MRI-guided biopsy and /or ablation procedure)
Secondary Outcomes (1)
Software ease of use in targeting lesion for treatment
Baseline (completion of MRI-guided biopsy and /or ablation procedure)
Study Arms (1)
MRI guided procedure software evaluation
EXPERIMENTALEvaluate the workflow and effectiveness of the Philips Interventional iSuite software during biopsies and/or ablations versus standard MR imaging in aiding needle placement.
Interventions
MRI guided ablation/biopsy using standard MR imaging along with Philips Interventional iSuite software tools.
Eligibility Criteria
You may qualify if:
- Patients already scheduled for a percutaneous MR guided procedure
You may not qualify if:
- Pregnant Women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- Philips Healthcarecollaborator
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
David A Woodrum, M.D., Ph.D.
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 2, 2018
First Posted
February 14, 2018
Study Start
June 1, 2021
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share